ALLERGY THER. PLC LS-001
Research ALLERGY THER. PLC LS-001 (HHU) on Bullrun: market cap EUR 490.56M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerHHU
- ExchangeF
- CountryUnited Kingdom
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 490.56M
- Financial periodFY2025
- RevenueEUR 55.04M
- Revenue growth-0.3%
- Net income-EUR 40.13M
- Free cash flow-EUR 31.53M
- Gross margin53.2%
Valuation Snapshot
latest market cap is EUR 490.56M.
About ALLERGY THER. PLC LS-001
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products.
Frequently asked questions
What is ALLERGY THER. PLC LS-001's market cap?
ALLERGY THER. PLC LS-001's market capitalization is EUR 490.56M.
What does ALLERGY THER. PLC LS-001 do?
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.